Merck KGaA (OTCMKTS:MKKGY) Sees Unusually-High Trading Volume – What’s Next?

Merck KGaA (OTCMKTS:MKKGY) saw unusually-high trading volume on Monday . Approximately 185,387 shares changed hands during mid-day trading, an increase of 157% from the previous session’s volume of 72,243 shares.The stock last traded at $30.70 and had previously closed at $29.94.

Merck KGaA Stock Up 2.6%

The stock has a market cap of $19.85 billion, a P/E ratio of 12.24, a P/E/G ratio of 6.09 and a beta of 0.95. The company has a quick ratio of 0.97, a current ratio of 1.49 and a debt-to-equity ratio of 0.36. The company has a 50-day simple moving average of $27.62 and a two-hundred day simple moving average of $26.61.

Merck KGaA (OTCMKTS:MKKGY) last issued its earnings results on Thursday, November 13th. The company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.54 by $0.27. Merck KGaA had a net margin of 13.92% and a return on equity of 10.07%. The company had revenue of $6.17 billion for the quarter, compared to the consensus estimate of $6.08 billion. On average, equities analysts forecast that Merck KGaA will post 1.87 EPS for the current year.

About Merck KGaA

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.